BPC-157
Evidence is predominantly preclinical (animal models) and recent reviews; large human clinical trials are not yet available.
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury
In a rat model of lower-extremity ischemia-reperfusion injury, the authors reported that BPC 157 administration was associated with reduced tissue-damage markers compared with untreated controls.
View study βFrom Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management
This review surveyed the published preclinical literature on BPC-157, summarising reported mechanisms in tissue repair and pain-related pathways and noting that the evidence base is predominantly from animal models.
View study βRegeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
This narrative review reported that BPC-157 shows regenerative activity across numerous animal models but emphasised that only a handful of small human pilot studies exist, so clinical validation is lacking.
View study βMultifunctionality and Possible Medical Application of the BPC 157 Peptide β Literature and Patent Review
This literature and patent review catalogued the multifunctional activities of the BPC 157 peptide described in animal studies and patent filings, while also raising open questions about its safety profile.
View study βProvided for educational and reference purposes only. These materials are sold strictly for laboratory research and are not for human or animal use.